argenx SE (OTCPK:ARGNF)
$ 373.5 0 (0%) Market Cap: 21.95 Bil Enterprise Value: 18.79 Bil PE Ratio: 0 PB Ratio: 5.35 GF Score: 80/100

argenx SE at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2020 / 05:30PM GMT
Release Date Price: $256.19
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Quickly before we get started, I just need to read a disclosure statement. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley representative.

With that, very pleased to have argenx with me and Tim Van. Tim, I can never say your last name. I'm sorry.

Timothy Van Hauwermeiren
argenx SE - CEO & Executive Director

Just call it Tim.

Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Tim, who's CEO; and Keith Woods, who's the COO.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot